Search clinical trials for: Forsteo

Total 42 results

University of Edinburgh
NHS Lothian

Recruiting

Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid (TOPaZ)

Osteogenesis Imperfecta

United Kingdom, Ireland
Amgen

Completed

An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women (STRUCTURE)

Postmenopausal Osteoporosis

Canada, Belgium, United States, Czechia, Denmark, Poland, Hungary, Spain, Colombia, United Kingdom, Argentina
Saint Petersburg State University, Russia

Completed

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). (TeriCa)

Hypocalcemia | Secondary Hyperparathyroidism | Dialysis | Hypoparathyroidism | Chronic Kidney Disease-Mineral and Bone Disorder

Russian Federation
Amgen

Completed

Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density

Postmenopausal Osteoporosis | Low Bone Mineral Density
STADA, Spain
Hospital Universitario Virgen Macarena; Alpha Bioresearch S.L.; Hospital Universitario... and other collaborators

Active, not recruiting

Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile. (ESECTO)

Osteoporosis

Spain
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism (ACTICAS)

Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment

France
University of Aarhus

Terminated

The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta

Osteogenesis Imperfecta

Denmark
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

Postmenopausal Osteoporosis

China
Seoul National University Bundang Hospital

Unknown

Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial

Spine Deformity

Korea, Republic of
Eli Lilly and Company

Completed

VERtebral Fracture Treatment Comparisons in Osteoporotic Women (VERO)

Postmenopausal Osteoporosis

United States, Germany, Hungary, Italy, Spain, Belgium, France, Poland, Austria, Canada, Puerto Rico, Argentina, Greece, Brazil, Czechia
Oregon Health and Science University
Eli Lilly and Company; National Institutes of Health (NIH); National Center for... and other collaborators

Completed

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta (OI)

Osteogenesis Imperfecta

United States
Zosano Pharma Corporation

Completed

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

Osteoporosis
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action (Forsteo)

Osteoporosis

United Kingdom
Radius Health, Inc.

Completed

Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women (ACTIVE)

Osteoporosis | Postmenopausal Osteoporosis

Hong Kong, United States, Poland, Romania, Estonia, Czech Republic, Argentina, Brazil, Denmark, Lithuania
Nottingham University Hospitals NHS Trust

Unknown

Ankle Fractures Treated With Teriparatide

Fracture, Ankle

United Kingdom
Zosano Pharma Corporation

Completed

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Postmenopausal Osteoporosis

United States
Eli Lilly and Company

Completed

Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis

Osteoporosis

United States, Canada
Eli Lilly and Company

Completed

Effect of Teriparatide on Hip Fracture Healing

Femur Neck Fracture

India, United States, Spain, Taiwan, Denmark, Australia, Sweden, Finland, Korea, Republic of, Israel, Japan, Hong Kong, Canada, Estonia, Latvia, Lithuania, New Zealand, Norway, Puerto Rico
Eli Lilly and Company

Completed

Second Study of the Effect of Teriparatide on Hip Fracture Healing

Femur Neck Fracture

Germany, United States, Belgium, France, Hungary, Croatia, Korea, Republic of, Greece, India, Switzerland, Romania, Netherlands, Poland, Turkey
Eli Lilly and Company

Completed

The Forteo Alendronate Comparator Trial (FACT)

Osteoporosis

United States, Brazil, Mexico, Puerto Rico
Glostrup University Hospital, Copenhagen
The Danish Medical Research Council

Withdrawn

Effect of PTH(1-34) Treatment on Fracture Healing in Vivo

Shoulder Fractures | Trochanteric Fractures

Denmark
Gedeon Richter Plc.

Completed

A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

Healthy

United Kingdom
University of Zurich

Unknown

A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)

Low Bone Mass in Anorexia Nervosa Patients

Switzerland
Nottingham University Hospitals NHS Trust

Unknown

Nasally and sc Administered Teriparatide in Healthy Volunteers (NINTTO)

Osteoporosis

United Kingdom
Eli Lilly and Company

Completed

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Osteoporosis, Post-menopausal

United States, Canada
Unigene Laboratories Inc.
GlaxoSmithKline

Completed

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

Postmenopausal Osteoporosis

Denmark, Estonia
Eli Lilly and Company

Completed

A Study of Teriparatide in Japanese Osteoporosis Patients

Osteoporosis

Japan
Eli Lilly and Company
TransPharma Medical

Completed

A Study for the Transdermal Application of Teriparatide

Osteoporosis

Hungary, Romania, Mexico, Argentina, Estonia
Eli Lilly and Company

Completed

Study of FORTEO Use in Subjects in the Community Setting (DANCE)

Osteoporosis

United States
Eli Lilly and Company

Completed

Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis (EuroGIOPS)

Osteoporosis

Germany, Italy, Greece, Spain
Eli Lilly and Company

Completed

A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide

Osteoporosis, Postmenopausal

United States, Canada
Eli Lilly and Company

Completed

Back Pain in Patients With Severe Osteoporosis

Osteoporosis

India, Mexico, Hong Kong, Taiwan, Korea, Republic of, Thailand, Malaysia, Pakistan, Singapore
Eli Lilly and Company

Completed

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

Back Pain | Osteoporosis, Postmenopausal | Spinal Fracture

Italy, Mexico, Australia, United States, Germany, Belgium, Puerto Rico, Sweden, Brazil, France, Canada, Spain, Argentina
Novartis

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

Post-menopausal Osteoporosis

Germany, Denmark
Novartis

Completed

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

Osteoporosis

United States, Belgium, Germany, Spain
Eli Lilly and Company

Completed

Phase 3 Clinical Trial of Teriparatide in Japan

Osteoporosis

Japan
Eli Lilly and Company

Completed

Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis

Osteoporosis

United Kingdom
Eli Lilly and Company

Completed

A Study for Patients With Osteoporosis

Osteoporosis

China
University of Michigan
Eli Lilly and Company

Completed

Impact of Parathyroid Hormone (PTH) on Osseous Cavity

Periodontitis | Bone Loss

United States
TransPharma Medical
Eli Lilly and Company

Completed

Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis

Osteoporosis

Israel, Czech Republic, Hungary
Eli Lilly and Company

Completed

Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis

Osteoporosis

Belgium, Norway, Austria, United States, Denmark, Puerto Rico
Eli Lilly and Company

Completed

Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

United States, Belgium, Canada, Austria, Czech Republic, Denmark, Netherlands, New Zealand, Sweden, Finland, Argentina, Australia, Hungary, Israel, Italy, Norway, Poland

Search clinical trials for: Forsteo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations